Literature DB >> 17895820

Terson syndrome with bilateral optic nerve sheath hemorrhage.

Chiaki D Gauntt1, Richard G Sherry, Chithra Kannan.   

Abstract

A 53-year-old man presented with an acute headache and mental status changes due to rupture of an anterior choroidal artery aneurysm. A preoperative CT scan demonstrated subarachnoid hemorrhage, bilateral optic nerve sheath hemorrhage, and bilateral intraocular hemorrhage. Ophthalmoscopy and B-scan ocular ultrasound disclosed vitreous hemorrhages, features consistent with Terson syndrome. This is the first CT report of Terson syndrome showing bilateral optic nerve sheath hemorrhage.

Entities:  

Mesh:

Year:  2007        PMID: 17895820     DOI: 10.1097/WNO.0b013e31814b22dc

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  4 in total

1.  Magnetic resonance imaging findings of Terson's syndrome suggesting a possible vitreous hemorrhage mechanism.

Authors:  Masashi Sakamoto; Kimitoshi Nakamura; Maho Shibata; Kunio Yokoyama; Mitsuru Matsuki; Tsunehiko Ikeda
Journal:  Jpn J Ophthalmol       Date:  2010-04-18       Impact factor: 2.447

2.  Clinical characteristics of asymptomatic Terson syndrome in the patients with aneurysmal subarachnoid hemorrhage.

Authors:  Hae Min Kang; Jin Mo Cho; So Yeon Kim; Jeong Hoon Choi
Journal:  Int J Ophthalmol       Date:  2020-02-18       Impact factor: 1.779

3.  Terson syndrome in subarachnoid hemorrhage, intracerebral hemorrhage, and traumatic brain injury.

Authors:  Patrick Czorlich; Christos Skevas; Volker Knospe; Eik Vettorazzi; Gisbert Richard; Lars Wagenfeld; Manfred Westphal; Jan Regelsberger
Journal:  Neurosurg Rev       Date:  2014-08-31       Impact factor: 3.042

4.  Ocular ultrasound as an easy applicable tool for detection of Terson's syndrome after aneurysmal subarachnoid hemorrhage.

Authors:  Patrick Czorlich; Till Burkhardt; Volker Knospe; Gisbert Richard; Eik Vettorazzi; Lars Wagenfeld; Manfred Westphal; Jan Regelsberger; Christos Skevas
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.